tiprankstipranks
Trending News
More News >

OptiBiotix Health Appoints New Broker to Strengthen Market Position

Story Highlights
OptiBiotix Health Appoints New Broker to Strengthen Market Position

Don’t Miss TipRanks’ Half-Year Sale

An update from OptiBiotix Health ( (GB:OPTI) ) is now available.

OptiBiotix Health plc has appointed Cairn Financial Advisers LLP as its new broker, a move that may enhance its financial advisory capabilities. This change could potentially impact the company’s strategic operations and market positioning, as it continues to focus on developing innovative health products targeting obesity, cardiovascular health, and diabetes.

More about OptiBiotix Health

OptiBiotix Health plc is a life sciences company focused on developing products that modify the human microbiome to prevent and manage diseases and promote wellness. Founded in 2012, the company engages in extensive R&D, collaborating with leading academics to create microbial strains and formulations for use in food and healthcare supplements. OptiBiotix’s market focus includes obesity, cardiovascular health, and diabetes, and it has agreements with over twenty international companies to incorporate its microbiome modulators into various products.

Average Trading Volume: 379,347

Technical Sentiment Signal: Sell

Current Market Cap: £11.62M

See more insights into OPTI stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1